SGHT (Sight Sciences, Inc.) Stock Financials & Earnings

SGHTSight Sciences, Inc.

Mkt Cap$224M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$77M

Net Income (TTM)-$38M

EPS (TTM)-$0.75

Free Cash Flow (TTM)-$30M

Gross Margin86.2%

Op. Margin-48.0%

Net Margin-49.7%

FCF Margin-38.7%

P/S Ratio (TTM)2.9x

P/E Ratio (TTM)—

YoY Rev Growth-3.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$19M	$16M	-$18M
Q2 23	$23M	$20M	-$15M
Q3 23	$20M	$17M	-$13M
Q4 23	$19M	$16M	-$11M
Q1 24	$19M	$16M	-$15M
Q2 24	$21M	$18M	-$13M
Q3 24	$20M	$17M	-$11M
Q4 24	$19M	$17M	-$12M
Q1 25	$18M	$15M	-$14M
Q2 25	$20M	$17M	-$12M
Q3 25	$20M	$17M	-$8M
Q4 25	$20M	$18M	-$4M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$5M	—	—	$29M
Q2 23	$5M	—	—	$30M
Q3 23	$4M	—	—	$27M
Q4 23	$3M	$22M	$2M	—
Q1 24	$5M	—	—	$27M
Q2 24	$4M	—	—	$27M
Q3 24	$5M	—	—	$23M
Q4 24	$4M	$23M	$1M	—
Q1 25	$4M	—	—	$25M
Q2 25	$4M	—	—	$24M
Q3 25	$3M	—	—	$22M
Q4 25	$2M	—	—	$19M

Revenue Segments

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$167M	$0	$167M
Q2 23	$155M	$0	$155M
Q3 23	$145M	$0	$145M
Q4 23	$138M	$0	$138M
Q1 24	$127M	$0	$127M
Q2 24	$118M	$0	$118M
Q3 24	$119M	$0	$119M
Q4 24	$120M	$0	$120M
Q1 25	$109M	$0	$109M
Q2 25	$102M	$0	$102M
Q3 25	$92M	$0	$92M
Q4 25	$92M	$0	$92M

Shares Outstanding

Revenue Per Employee

Revenue / Employee